DCT

1:22-cv-00061

Regeneron Pharma Inc v. Mylan Pharma Inc

General
Filed
08/02/22
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (06/21/24)
Patent Owner
Operating Company (W)
Nature of Suit830 Patent
Judge
Period
PO Win Rate
--
80%